Novel precision therapies for cholangiocarcinoma: an overview of clinical trials
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2023.2173064
Abstract: ABSTRACT Introduction The treatment landscape of biliary cancers is rapidly changing. Inhibitors against the actionable targets FGFR and IDH1 are now being included in the treatment guidelines of multiple countries for patients with advanced cholangiocarcinoma.… read more here.
Keywords: precision therapies; clinical trials; novel precision; therapies cholangiocarcinoma ... See more keywords